Secure your simplified biologics supply

To support your commercial success, Lonza is expanding large-scale biologics drug product manufacturing in Stein, Switzerland, providing you with end-to-end solutions through our global network, that can enable seamless integration of drug substance and drug product for mammalian, microbial-based and bioconjugate modalities.

Partner with us

No DataSource has been set for this component or there is a component error.

If you are:

In need of additional drug product capacities
Experiencing supplier challenges and considering alternatives
Looking to simplify your supplier network through an integrated drug substance/drug product (DS/DP) supplier
Seeking a trusted manufacturing partner for launching your biologics

Then you're in good hands with Lonza. Partner with us today for your upcoming manufacturing needs.

Dive deeper with our Q&A

This Q&A details our added capabilities and how they can benefit biopharmaceutical and biotech companies like yours. From how your supply chain can be simplified through our integrated drug product network, to operational readiness, take a deeper dive into how we're growing for you.

Have a minute?

Read the Q&A

Simplify your supply chain

Integrated across the value chain
Leveraging a robust global biologics network, that enables integration of Drug Substance (DS) and Drug Product (DP) manufacturing for mammalian, microbial, and bioconjugate modalities.

Comprehensive dosage form coverage
Capabilities across a wide range of biologics formats, including liquid and lyophilized vials, prefilled syringes (PFS), and cartridges.

Along the full lifecycle
From early-stage development to commercial-scale manufacturing, we provide full lifecycle support—enhanced by specialized capabilities such as:

Forensics-On-Demand™ for rapid particle identification
New presentation development, including high-concentration formulations and complex delivery systems like prefilled syringes

Mitigate your risk

Strong expertise
Anchored at the heart of the pharma/biotech hub in Basel. Over 20 years of average industry experience among leadership team.

Leaders in GMP Annex 1 Compliance
Pioneering best practices and regulatory alignment.

Proven tech transfer capabilities
Successfully executed more than 150 technology transfers in the past five years.

Powered by innovation
Advanced automation, precision filling, and predictive analytics at the core of our operations.

Develop a sustainable partnership for today, tomorrow and beyond

Committed to sustainability
Awarded the EcoVadis Silver Medal and aligned with the Science Based Targets initiative, we integrate sustainability into every facet of our operations.

Investing to guide Your Evolving Needs
With 22 active growth projects, we’re scaling capacities and advancing technologies to support your future requirements.

A true partnership model
We work side by side with our customers, delivering tailored solutions that align with their unique goals. 

Expand with us

Fulfill your evolving market needs

In the dynamic landscape of biologics, demand for a product can shift rapidly due to clinical outcomes, regulatory changes, or market forces. For pharma/biotech companies, these fluctuations present significant challenges—ranging from the need to quickly scale production up or down, to maintaining supply continuity without compromising quality or compliance. In such moments, having a flexible and responsive CDMO partner becomes critical.

Agility, expertise and capacity

We combine agility, deep technical expertise, and scalable capacity to respond swiftly and effectively to dynamic market demands.